Sweeneys to make room for new leadership at Dorland
L-r: Rich Minoff will become president/CEO of Dorland Global, succeeding Rita and Harry Sweeney
The 125-person agency maintains two business units, advertising and PR. Clients include Johnson & Johnson, Roche and Boston Scientific.
“Harry and I are confident that [Minoff] will not only continue to service our clients and employees in the manner that Dorland Global is known for, but will also take the agency in a new direction with the Huntsworth organization,” said Rita Sweeney, who had served as president, chief operating officer. The COO position will be eliminated. Her husband is stepping down as CEO.
Minoff joined the agency in 2002 as president of Dorland Global Health Communications, a branding and marketing division which has grown 47% per year under his watch. In addition, he has 14 years of senior managerial experience at various agencies, along with 12 years on the client side working for GlaxoSmithKline and Wyeth.
Thanks to the March purchase, Dorland Global's two main business units, Dorland Global Health Communications and Dorland Global Public Relations, now serve as the US affiliate of the UK-based Huntsworth health division.